Patents by Inventor Sadao Susumi

Sadao Susumi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4954340
    Abstract: A preparation for activating hemocytes of bivalves for pearl production containing a mitogen as an effective component, and a method for producing pearl through nucleus insertion operation of a bivalve for pearl production which comprises treating a section of the mantle part of a donor to be inserted with a mitogen.By the treatment with the present preparation, hemocytes of the wound site due to the nucleus insertion operation are activated, tissue growth of the section of the mantle part of the donor is accelerated and a good pearl sac is formed around the nucleus. As a result, the number ejected nuclei is decreased and the pearl quality and production amount are enhanced.These effects are further enhanced by using a mitogen treated with an aluminum adjuvant or the like.
    Type: Grant
    Filed: August 2, 1988
    Date of Patent: September 4, 1990
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Haruhisa Maeda, Akira Tsujikawa, Sadao Susumi
  • Patent number: 4885359
    Abstract: Improved method for the purification of LPF-HA (Leucocytosis promoting far hemagglutinin) on industrial scale which comprises contacting a LPF-HA-containing solution from culture media of Bordetella pertussis with a cellulose sulfate gel, a crosslinked polysaccharide sulfate gel, or a polysaccharide gel chemically bound with dextran sulfate, thereby adsorbing LPF-HA on the gel, and then eluting LPF-HA from the gel. Said method can give a highly purified LPF-HA which does not contain any other proteins, lipid, saccharides, etc. and further undesirable endotoxin, and hence can be used for producing various reagents, medicines and pertussis vaccine.
    Type: Grant
    Filed: November 16, 1987
    Date of Patent: December 5, 1989
    Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
    Inventors: Akihiro Ginnaga, Tsukasa Nishihara, Tetsuo Kawahara, Sadao Susumi, Hiroshi Mizokami, Mitsuo Sakoh
  • Patent number: 4563303
    Abstract: Improved method for the purification of filamentous hemagglutinin (F-HA) on industrial scale which comprises contacting a culture of a microorganism of the genus Bordetella with a cellulose sulfate gel, a polysaccharide gel chemically bound with dextran sulfate, or a crosslinked polysaccharide sulfate gel, thereby adsorbing F-HA on the gel, and then eluting F-HA from the gel. Said method can give a highly purified F-HA which does not contain any other proteins, lipid, saccharides, etc. and further undesirable endotoxin, and hence can be used for producing various reagents, medicines and pertussis vaccine.
    Type: Grant
    Filed: April 12, 1985
    Date of Patent: January 7, 1986
    Assignee: Judicial Foundation The Chemosero-Therapeutic Research Institute
    Inventors: Akihiro Ginnaga, Shin Sakuma, Tsukasa Nishihara, Tomitaka Tashiro, Sadao Susumi, Tetsuo Kawahara, Hiroshi Mizokami
  • Patent number: 4515714
    Abstract: An improved method for the purification of hepatitis B virus surface anti by column chromatography, which is characteristic in using as a gel for the chromatography a sulfuric acid ester of a crosslinked polysaccharide or cellulose which is obtained by sulfating a crosslinked polysaccharide or cellulose. Said method can give a highly purified hepatitis B virus surface antigen which is useful for the preparation of hepatitis B virus vaccine.
    Type: Grant
    Filed: March 6, 1984
    Date of Patent: May 7, 1985
    Assignee: Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute
    Inventors: Tetsuo Kawahara, Hiroshi Mizokami, Kyosuke Mizuno, Sadao Susumi